Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 24/08/02

Trade details

Type: Insider sale
Amount: $46,822.02
Shares · price: 1,702 sh · $27.51 a share
Held after: 131,643 sh
Stock: Enliven Therapeutics ELVN
Person: Richard A. HeymanDirector
Trade date: 24/07/31
Filed: 24/08/02
Days to filing: 2 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/01~24/08/30

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$45.2K
3,500 sh
$45.2K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$41.3K
3,200 sh
$41.3K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$109.1K
8,100 sh
$109.1K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04

Richard A. Heyman, Director — sold $46.8K of Enliven Therapeutics ELVN · 1.3% of holdings · 10b5-1 plan | Whalegun